These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 39408773)

  • 1. SHH Signaling as a Key Player in Endometrial Cancer: Unveiling the Correlation with Good Prognosis, Low Proliferation, and Anti-Tumor Immune Milieu.
    Snijesh VP; Krishnamurthy S; Bhardwaj V; Punya KM; Niranjana Murthy AS; Almutadares M; Habhab WT; Nasser KK; Banaganapalli B; Shaik NA; Albaqami WF
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated Identification and Immunotherapy Response Analysis of the Prognostic Signature Associated With m6A, Cuproptosis-Related, Ferroptosis-Related lncRNA in Endometrial Cancer.
    Qian Y; Chen H; Miao P; Ma R; Lu B; Hu C; Fan R; Xu B; Chen B
    Cancer Rep (Hoboken); 2024 Sep; 7(9):e70009. PubMed ID: 39324703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A stemness-based signature with inspiring indications in discriminating the prognosis, immune response, and somatic mutation of endometrial cancer patients revealed by machine learning.
    Pang X; Wang Y; Zhang Q; Qian S
    Aging (Albany NY); 2024 Jul; 16(14):11248-11274. PubMed ID: 39079132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
    Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
    BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
    Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
    Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
    Lai J; Xu T; Yang H
    BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.
    Cheng P; Ma J; Zheng X; Zhou C; Chen X
    Sci Rep; 2021 Jun; 11(1):12608. PubMed ID: 34131259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.
    Ma H; Feng PH; Yu SN; Lu ZH; Yu Q; Chen J
    BMC Cancer; 2022 May; 22(1):543. PubMed ID: 35562682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
    Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
    Front Immunol; 2021; 12():805883. PubMed ID: 35095892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sonic hedgehog signaling pathway in Myelodysplastic Syndrome: Abnormal activation and jervine intervention.
    Qin Y; Jiang M; Tuerxung N; Wang H; Zhao F; Zhen Y; Hao J
    Gene; 2020 Sep; 754():144881. PubMed ID: 32526259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immunologic tumor microenvironment in endometrioid endometrial cancer in the morphomolecular context: mutual correlations and prognostic impact depending on molecular alterations.
    Willvonseder B; Stögbauer F; Steiger K; Jesinghaus M; Kuhn PH; Brambs C; Engel J; Bronger H; Schmidt GP; Haller B; Weichert W; Keller G; Noske A; Pfarr N; Boxberg M
    Cancer Immunol Immunother; 2021 Jun; 70(6):1679-1689. PubMed ID: 33340331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of HOX family regulator-mediated modification patterns and immunity characteristics on tumor-associated cell type in endometrial cancer.
    Yang J; Li J; Li S; Yang Y; Su H; Guo H; Lei J; Wang Y; Wen K; Li X; Zhang S; Wang Z
    Mol Biomed; 2024 Aug; 5(1):32. PubMed ID: 39138733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
    Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
    Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cuproptosis-Associated lncRNA Gene Signature Establishes New Prognostic Profile and Predicts Immunotherapy Response in Endometrial Carcinoma.
    Jiang XY; Hu JJ; Wang R; Zhang WY; Jin QQ; Yang YT; Mei J; Hong L; Yao H; Tao F; Li JJ; Liu Y; Zhang L; Chen SX; Chen G; Song Y; Zhou SG
    Biochem Genet; 2024 Oct; 62(5):3439-3466. PubMed ID: 38108937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic and immune-related gene signatures in the tumor microenvironment of endometrial cancer.
    Wang G; Wang D; Sun M; Liu X; Yang Q
    Int Immunopharmacol; 2020 Nov; 88():106931. PubMed ID: 32889237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of an immune gene prognostic classifier for survival prediction and respond to immunocheckpoint inhibitor therapy/chemotherapy in endometrial cancer.
    Liu J; Chen X; Jiang Y; Cheng W
    Int Immunopharmacol; 2020 Sep; 86():106735. PubMed ID: 32619957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unraveling the ecological landscape of mast cells in esophageal cancer through single-cell RNA sequencing.
    Zhang S; Zhang X; Xiahou Z; Zuo S; Xue J; Zhang Y
    Front Immunol; 2024; 15():1470449. PubMed ID: 39430754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of the Immune Microenvironment in Endometrial Cancer.
    Lee M; Jung W; Kang J; Lee KH; Lee SJ; Hong SH; Kang J; Lee A
    Lab Invest; 2024 Sep; 104(9):102126. PubMed ID: 39174007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-plex spatial transcriptomic profiling reveals distinct immune components and the HLA class I/DNMT3A/CD8 modulatory axis in mismatch repair-deficient endometrial cancer.
    Guo J; Tang B; Fu J; Zhu X; Xie W; Wang N; Ding Z; Song Z; Yang Y; Xu G; Xiao X
    Cell Oncol (Dordr); 2024 Apr; 47(2):573-585. PubMed ID: 37847338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mismatch repair deficiency and aberrations in the Notch and Hedgehog pathways are of prognostic value in patients with endometrial cancer.
    Polychronidou G; Kotoula V; Manousou K; Kostopoulos I; Karayannopoulou G; Vrettou E; Bobos M; Raptou G; Efstratiou I; Dionysopoulos D; Chatzopoulos K; Lakis S; Chrisafi S; Tsolakidis D; Papanikolaou A; Dombros N; Fountzilas G
    PLoS One; 2018; 13(12):e0208221. PubMed ID: 30521558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.